Description: Critical Illness (CI) insurance in Asia has evolved through data-driven insights, adapting to changing medical, demographic, and lifestyle trends. Gen Re’s CI Data Insights Study, covering Mainland China, Hong Kong, Singapore, Malaysia, and Thailand, highlights how advances in screening, especially for cancers, have influenced incidence rates and claims. Regular updates to CI definitions and product structures are essential for sustainability, as seen in the handling of thyroid and prostate cancers. Lifestyle factors like BMI also impact cardiovascular risk. A multi-dimensional approach combining robust data monitoring, proactive product updates, and wellness promotion ensures CI insurance remains relevant and sustainable.

Description: Voluntary health insurance coverage options are described including hospital indemnity, accident plans, disability insurance, and critical illness policies.

Description: Analysis of Alzheimer’s Disease as a potential Critical Illness insurance benefit trigger.

Description: Features of Critical Illness products

Description: Source: This document is a whitepaper sourced from a health insurance industry analysis. It provides a detailed overview of the evolution and strategic importance of voluntary benefits within employer-sponsored health plans in the United States. Intent: The paper aims to inform healthcare stakeholders—particularly employers, insurers, and HR professionals—about the role of voluntary benefits in filling coverage gaps left by major medical plans. It outlines the historical development, market drivers, regulatory context (especially post-ACA), and future trends, with a focus on personalization, digital integration, and financial protection. Value: This resource offers practical insights and strategic guidance for enhancing benefits design and employee engagement.

Description: Discussion of recent developments in the taxation of noncoordinated benefits such as fixed indemnity, hospital indemnity, and specified disease insurance policies. Developments include a recent Chief Counsel Advice Memorandum and proposed triagency rulemaking that would impact non coordinated benefits.

Description: Heatmaps are an effective tool for visualizing changes in cancer incidences over time in large datasets. They can show the impact of screening measures, particularly when targeting specific age groups, and reveal characteristics of individual cohorts.

Description: The last three decades have witnessed an important rise in number of people with diabetes in Asia, especially Type 2 Diabetes. Like no other common condition, numerous innovations are currently entering the healthcare system that will soon have a significant impact on management of the condition. This presentation explores the role played by sensors/wearables, artificial intelligence, new drugs and diabetes apps. We assess the realistic potential of such advancements and give an outlook on medium-term pricing and product development.

Description: Typical features of Critical Illness policies, and discussion of pricing, reserving, claims experience and regulations.